News|Articles|December 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-12-02-2004
  • Volume 28
  • Issue 11

Robust CRO Market Is Driving New Merger and Acquisition Activity

Author(s)Jim Miller

The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.